Oncology Product Guide » mTOR kinase http://www.oncologyproductguide.com/blog A comprehensive guide to oncology products for medical professionals Fri, 11 Jun 2010 12:00:01 +0000 http://wordpress.org/?v=2.8.2 en hourly 1 Intellikine Initiates Phase I Clinical Trial For Targeted Anticancer Drug INK128 http://www.oncologyproductguide.com/blog/2010/01/08/intellikine-initiates-phase-i-clinical-trial-for-targeted-anticancer-drug-ink128/ http://www.oncologyproductguide.com/blog/2010/01/08/intellikine-initiates-phase-i-clinical-trial-for-targeted-anticancer-drug-ink128/#comments Fri, 08 Jan 2010 12:18:55 +0000 Jim Marino http://www.oncologyproductguide.com/blog/?p=202 Intellikine, Inc.Intellikine, Inc. has initiated a Phase I clinical trial for its targeted anticancer drug INK128, a novel orally-available small molecule inhibitor of both the TORC1 and TORC2 complexes. The mTOR kinase represents a central node in human cancer biology and has become an important target for oncology drug development. Unlike other drugs targeting the pathway, INK128 directly inhibits the activity associated with both the TORC1 and TORC2 complexes of the mTOR kinase.

For the full story, Click Here

]]> http://www.oncologyproductguide.com/blog/2010/01/08/intellikine-initiates-phase-i-clinical-trial-for-targeted-anticancer-drug-ink128/feed/ 0